TP53 and cancer: PAAD includes not only KRAS and TP53 mutations but also high hypoxia levels, which induces the glycolysis pathway in cancer (Kamisawa et al., 2016) (Yang et al., 2020) (Lin et al., 2018) (Nagdas et al., 2019).